USP14 inhibitors have shown significant potential in cancer therapy, particularly for colorectal cancer, by suppressing tumour growth, enhancing chemotherapy and radiotherapy effectiveness, and overcoming drug resistance [37, 38]. The gene discussed is USP14; the disease is neoplasm.